PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Frequently asked questions
What sector does Elevai Labs Inc. Common Stock (ELAB) operate in?
Elevai Labs Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Elevai Labs Inc. Common Stock (ELAB) current stock price?
As of the latest data, Elevai Labs Inc. Common Stock stock price is $2.52, with a previous close of $2.61. Elevai Labs Inc. Common Stock lost -$0.09 in the last trading session, representing a -3.45% loss.
What is Elevai Labs Inc. Common Stock (ELAB) current market capitalization?
Elevai Labs Inc. Common Stock market cap is approximately 2.04 million.
What is Elevai Labs Inc. Common Stock (ELAB) Earnings Per Share (EPS)?
The trailing EPS is -$1,675.79.
What is Elevai Labs Inc. Common Stock (ELAB) EBITDA?
Elevai Labs Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.51 million.
Does Elevai Labs Inc. Common Stock (ELAB) pay dividends?
No. Elevai Labs Inc. Common Stock does not pay a dividend.
When is Elevai Labs Inc. Common Stock (ELAB) next earnings report?
Elevai Labs Inc. Common Stock is expected to release its next earnings report on September 30, 2026.
What is Elevai Labs Inc. Common Stock (ELAB) beta (volatility) score?
Elevai Labs Inc. Common Stock has a beta of -0.296, indicating lower volatility than the overall market.
